Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma (ClinicalTrials.gov Identifier: NCT01928771) – Publicado no The Lancet
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma (ClinicalTrials.gov Identifier: NCT01928771) – Publicado no The Lancet
Consultoria Médica e Pesquisa Clínica. São 10 anos de experiência e 65 pesquisas clínicas realizadas. 2675 participantes triados e 1971 participantes randomizados.